| 國立臺灣大學 |
2009 |
Cost-Effectiveness of Human Papillomavirus Vaccine for Prevention of Cervical Cancer in Taiwan
|
劉邦祥; 王榮德; LIU, PANG-HSIANG; WANG, JUNG-DER |
| 臺大學術典藏 |
2020-01-14T03:33:10Z |
Cost-effectiveness of influenza control measures: A dynamic transmission model-based analysis
|
CHUNG-MIN LIAO; Liao C.-M.; Chen S.-C.; Chen S.-C.;Liao C.-M. |
| 中山醫學大學 |
2013-12 |
Cost-effectiveness of influenza control measures: a dynamic transmission model-based analysis.
|
Chen SC;Liao CM. |
| 嘉南藥理大學 |
2023 |
Cost-effectiveness of Intensive vs Standard Blood Pressure Control Among Older Patients With Hypertension
|
Zhang, Zhen-Yu; Melgarejo, Jesus; Wei, Dongmei; Hu, Angie; Sun, Li; Yang, Chun-Ting; Liao, Chia-Te; Toh, Han Siong |
| 國立成功大學 |
2023 |
Cost-effectiveness of Intensive vs Standard Blood Pressure Control Among Older Patients With Hypertension
|
Liao, C.-T.;Toh, H.S.;Sun, L.;Yang, C.-T.;Hu, A.;Wei, D.;Melgarejo, J.;Zhang, Zhang Z.-Y. |
| 國立成功大學 |
2021 |
Cost-Effectiveness of Juluca (dolutegravir/rilpivirine) for Human Immunodeficiency Virus (HIV-1) Infection Treatment in Virologically Suppressed Adults in Taiwan
|
Anderson, S.-J.;Hsu, C.-Y.;Ou, H.-T.;Ko, N.-Y.;Yang, C.-T.;Lopes, S. |
| 國立成功大學 |
2020-05 |
Cost-effectiveness of long-acting insulin analogues vs intermediate/long-acting human insulin for type 1 diabetes: A population-based cohort followed over 10 years
|
Lee;Tsung-Ying;Kuo;Shihchen;Yang;Chen-Yi;Ou;Huang-Tz |
| 國立成功大學 |
2021 |
Cost-Effectiveness of Nivolumab Plus Ipilimumab With and Without Chemotherapy for Advanced Non-Small Cell Lung Cancer
|
Yang, S.-C.;Kunst, N.;Gross, C.P.;Wang, J.-D.;Su, W.-C.;Wang, S.-Y. |
| 臺大學術典藏 |
2018-09-10T15:26:31Z |
Cost-effectiveness of non-surgical peri-implantitis treatments
|
Listl, S. ; Fr\\Uhauf, N. ; Dannewitz, B. ; Weis, C. ; Tu, Y.-K. ; Chang, H.-J. ; Faggion, C.M.; YU-KANG TU |
| 臺大學術典藏 |
2022-05-10T08:10:18Z |
Cost-effectiveness of non-surgical peri-implantitis treatments
|
Listl S.; Fr?hauf N.; Dannewitz B.; Weis C.; YU-KANG TU; Chang H.-J.; Faggion C.M. |
| 國立成功大學 |
2023-01-12 |
Cost-effectiveness of Novel Macrophage-Regulating Treatment for Wound Healing in Patients With Diabetic Foot Ulcers From the Taiwan Health Care Sector Perspective
|
Su;Hsuan-Yu;Yang;Chen-Yi;Ou;Huang-Tz;Chen;Shyi-Gen;Chen;Jui-Ching;Ho;Hui-Ju;Kuo;Shihchen |
| 國立成功大學 |
2007-09 |
Cost-effectiveness of peginterferon alfa-2a compared to lamivudine treatment in patients with hepatitis B e antigen positive chronic hepatitis B in Taiwan
|
Sean D Sullivan; David L Veenstra; Chen, Pei-Jer; Chang, Ting-Tsung; Chuang, Wan-Long; Tsai, Chiaming; Patel, Kavita |
| 國立臺灣大學 |
2007 |
Cost-Effectiveness of Peginterferon Alfa-2a Compared to Lamivudine Treatment in Patients with Hepatitis B E Antigen Positive Chronic Hepatitis B in Taiwan
|
陳培哲; 張定宗; 莊萬龍; CHEN, PEI-JER; CHANG, TING-TSUNG; CHUANG, WAN-LONG |
| 臺大學術典藏 |
2021-07-03T03:35:09Z |
Cost-effectiveness of peginterferon alfa-2a compared to lamivudine treatment in patients with hepatitis B e antigen positive chronic hepatitis B in Taiwan
|
Sullivan S.D.; Veenstra D.L.; PEI-JER CHEN; Chang T.-T.; Chuang W.-L.; Tsai C.; Patel K. |
| 國立臺灣大學 |
2007-09 |
Cost-effectiveness of peginterferon alpha-2a compared to lamivudine treatment in patients with hepatitis B e antigen positive chronic hepatitis B in Taiwan.
|
Sullivan, SD; Veenstra, DL; Chen, PJ; Chang, TT; Chuang, WL; Tsai, C; Patel, K. |
| 國立成功大學 |
2021-03-10 |
Cost-effectiveness of percutaneous coronary intervention versus medical therapy in patients with acute myocardial infarction: real-world and lifetime-horizon data from Taiwan
|
Liao;Chia-Te;Hsieh;Tung-Han;Shih;Chia-Yin;Liu;Ping-Yen;Wang;Jung-Der |
| 臺大學術典藏 |
2022-08-19T00:20:36Z |
Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection
|
Cheng A.-L.; CHIUN HSU; Taiwan Cooperative Oncology Group; Chen P.-J.; Tsui C.-W.; Wu H.-Y.; Hsu Y.-T.; Chuang M.-H.; Hsiung C.A.; Liu T.-W.; Yang H.-C.; Hsiao C.-F.; Tsou H.-H. |
| 國家衛生研究院 |
2019-06-21 |
Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection
|
Tsou, HH;Yang, HC;Hsiao, CF;Hsiung, CA;Liu, TW;Chuang, MH;Wu, HY;Hsu, YT;Tsui, CW;Chen, PJ;Cheng, AL;Hsu, C; the Taiwan Cooperative Oncology Group |
| 臺大學術典藏 |
2019-08-29T07:31:06Z |
Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection
|
Tsou, Hsiao-Hui;Hung-Chih Yang;Hsiao, Chin-Fu;Hsiung, Chao A;Liu, Tsang-Wu;Chuang, Mei-Hsing;Wu, Hsiao-Yu;Hsu, Ya-Ting;Tsui, Chiung-Wen;Pei-Jer Chen;Ann-Lii Cheng;Hsu, Chiun; Tsou, Hsiao-Hui; HUNG-CHIH YANG; Hsiao, Chin-Fu; Hsiung, Chao A; Liu, Tsang-Wu; Chuang, Mei-Hsing; Wu, Hsiao-Yu; Hsu, Ya-Ting; Tsui, Chiung-Wen; PEI-JER CHEN; ANN-LII CHENG; Hsu, Chiun |
| 臺大學術典藏 |
2020-04-10T12:50:59Z |
Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection
|
Tsou H.-H.;Yang H.-C.;Hsiao C.-F.;Hsiung C.A.;Liu T.-W.;Chuang M.-H.;Wu H.-Y.;Hsu Y.-T.;Tsui C.-W.;Chen P.-J.;Cheng A.-L.;Chiun Hsu;Taiwan Cooperative Oncology Group; Tsou H.-H.; Yang H.-C.; Hsiao C.-F.; Hsiung C.A.; Liu T.-W.; Chuang M.-H.; Wu H.-Y.; Hsu Y.-T.; Tsui C.-W.; Chen P.-J.; Cheng A.-L.; Chiun Hsu; Taiwan Cooperative Oncology Group |
| 臺大學術典藏 |
2021-07-12T02:44:25Z |
Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection
|
Tsou H.-H; | HUNG-CHIH YANG; | Hsiao C.-F; | Hsiung C.A; | Liu T.-W; | Chuang M.-H; | Wu H.-Y; | Hsu Y.-T; | Tsui C.-W; | Chen P.-J; | Cheng A.-L; | Hsu C; | Taiwan Cooperative Oncology Group |
| 臺大學術典藏 |
2021-07-03T03:33:29Z |
Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection
|
Tsou H.-H.; Yang H.-C.; Hsiao C.-F.; Hsiung C.A.; Liu T.-W.; Chuang M.-H.; Wu H.-Y.; Hsu Y.-T.; Tsui C.-W.; PEI-JER CHEN; Cheng A.-L.; Hsu C.; Taiwan Cooperative Oncology Group |
| 臺大學術典藏 |
2021-08-31T06:29:20Z |
Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection
|
Tsou H.-H.; Yang H.-C.; Hsiao C.-F.; Hsiung C.A.; Liu T.-W.; Chuang M.-H.; Wu H.-Y.; Hsu Y.-T.; Tsui C.-W.; Chen P.-J.; ANN-LII CHENG; Hsu C.; Taiwan Cooperative Oncology Group |
| 臺北醫學大學 |
2009 |
Cost-Effectiveness of Prophylactic Human Papillomavirus (HPV) Vaccine for Prevention of Cervical Cancer in A Country with High Prevalence of HPV Infection
|
Pang-Hsiang Liu; Fu-Chang Hu; Chao-Wan Huang;Jung-Der Wang |
| 國家衛生研究院 |
2013-11 |
Cost-effectiveness of rotavirus vaccination programs in Taiwan
|
Chang, WC;Yen, C;Chi, CL;Wu, FT;Huang, YC;Lin, JS;Huang, FC;Tate, JE;Wu, HS;Hsiung, CA |
